In light of insulin-related signaling’s importance in energy homeostasis, neuronal survival, and memory processes, and the fact that insulin resistance is associated with memory impairment and other AD symptoms, substances that modulate insulin signaling should be considered as potential AD treatments (55). The gene discussed is INS; the disease is memory impairment.